Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide for Coronary Endothelial Function in T2DM
NCT02584075Phase 4Unknown
- Sponsor
- Beijing Chaoyang Hospital
- Start
- Nov 2015
- Primary completion
- Nov 2017
- Modality
- Peptides
01
Overview
A Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by Beijing Chaoyang Hospital. Status: unknown.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02584075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02584075.